Bausch & Lomb (BLCO) director granted 15,842 RSUs in annual equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bernier Nathalie D. reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Nathalie D. Bernier received an annual equity award in the form of restricted share units (RSUs). She was granted 15,842 common shares at a reference price of $15.78 per share, increasing her direct holdings to 85,505 common shares.
The footnote explains this is the regular annual RSU grant to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. These RSUs will vest immediately before the next annual meeting of shareholders and will then be settled in common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bernier Nathalie D.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, No Par Value | 15,842 | $15.78 | $250K |
Holdings After Transaction:
Common Shares, No Par Value — 85,505 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSUs granted: 15,842 shares
Grant reference price: $15.78 per share
Shares held after grant: 85,505 shares
+1 more
4 metrics
RSUs granted
15,842 shares
Annual non-employee director award on May 26, 2026
Grant reference price
$15.78 per share
Reporting price for RSU grant
Shares held after grant
85,505 shares
Direct holdings following the RSU award
Transactions reported
1 transaction
Single acquisition (grant/award) on Form 4
Key Terms
restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, non-employee directors, vest
4 terms
2022 Omnibus Incentive Plan financial
"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"
non-employee directors financial
"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
vest financial
"The RSUs are scheduled to vest on the date immediately preceding the conclusion"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider transaction did Bausch & Lomb (BLCO) disclose for Nathalie D. Bernier?
Bausch & Lomb disclosed that director Nathalie D. Bernier received an annual equity award of 15,842 restricted share units. These RSUs will be settled in common shares after vesting and are part of the company’s standard non-employee director compensation.
What are the terms of the RSU grant reported for Bausch & Lomb (BLCO) director Nathalie D. Bernier?
The grant represents annual restricted share units to a non-employee director under the 2022 Omnibus Incentive Plan. The RSUs are scheduled to vest immediately before the next annual shareholder meeting, and vested units will be settled in Bausch & Lomb common shares.
Is the Bausch & Lomb (BLCO) Form 4 transaction an open-market purchase or a compensation grant?
The Form 4 shows a compensation-related grant, not an open-market purchase or sale. Code “A” indicates an award of 15,842 restricted share units granted as part of Nathalie D. Bernier’s annual non-employee director compensation package.
How is the value of the Bausch & Lomb (BLCO) RSU grant to Nathalie D. Bernier measured in the Form 4?
The filing lists a reference price of $15.78 per share for the 15,842 restricted share units. This price is used for reporting purposes on the Form 4 but does not represent an open-market trade price because the transaction is an equity award grant.